Literature DB >> 20670369

Relation between D-dimer level, venous valvular reflux and the development of post-thrombotic syndrome after deep vein thrombosis.

J Latella1, S Desmarais, M-J Miron, A Roussin, F Joyal, J Kassis, S Solymoss, L Desjardins, J S Ginsberg, S R Kahn.   

Abstract

BACKGROUND: The pathophysiology of post-thrombotic syndrome (PTS) is postulated to involve persistent venous obstruction and venous valvular reflux.
OBJECTIVE: To study the association between D-dimer level, valvular reflux and the PTS in a well-defined cohort of deep vein thrombosis (DVT) patients.
METHODS: Consecutive patients with acute symptomatic DVT were recruited at eight centers and were followed for 24months. D-dimer was measured at 4months. A standardized ultrasound assessment for popliteal valvular reflux was performed at 12months. Using the Villalta scale, patients were assessed for PTS during follow-up by evaluators who were unaware of D-dimer or reflux results.
RESULTS: Three hundred and eighty-seven patients were recruited; of these, 305 provided blood samples for D-dimer and 233 had a 12-month reflux assessment. PTS developed in 45.1% of subjects. Mean D-dimer was significantly higher in patients with vs. without PTS (712.0 vs. 444.0μgL(-1) ; P=0.02). In logistic regression analyses adjusted for warfarin use at the time of D-dimer determination and risk factors for PTS, D-dimer level significantly predicted PTS (P=0.03); when stratifying for warfarin use at the time of blood draw, adjusted odds ratio (OR) for developing PTS per unit difference in log D-dimer was 2.33 (95% CI 0.89, 6.10) in those not on warfarin vs. 1.25 (95% CI 0.87, 1.79) in those on warfarin. Ipsilateral reflux was more frequent in patients with moderate-to-severe PTS than in patients with mild PTS (65% vs. 40%, respectively; P=0.01) and was independently associated with moderate-to-severe PTS in logistic regression analyses (P=0.01).
CONCLUSION: D-dimer levels, measured 4months after DVT in patients not on warfarin, are associated with subsequent development of PTS. Venous valvular reflux is associated with moderate-to-severe PTS.
© 2010 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20670369     DOI: 10.1111/j.1538-7836.2010.04001.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  6 in total

Review 1.  Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors.

Authors:  Neil A Goldenberg; Marco P Donadini; Susan R Kahn; Mark Crowther; Gili Kenet; Ulrike Nowak-Göttl; Marilyn J Manco-Johnson
Journal:  Haematologica       Date:  2010-06-30       Impact factor: 9.941

Review 2.  Diagnosis of deep vein thrombosis, and prevention of deep vein thrombosis recurrence and the post-thrombotic syndrome in the primary care medicine setting anno 2014.

Authors:  Jan Jacques Michiels; Janneke Maria Michiels; Wim Moossdorff; Mildred Lao; Hanny Maasland; Gualtiero Palareti
Journal:  World J Crit Care Med       Date:  2015-02-04

3.  ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism.

Authors:  Carlo D'Agostino; Pietro Zonzin; Iolanda Enea; Michele Massimo Gulizia; Walter Ageno; Piergiuseppe Agostoni; Michele Azzarito; Cecilia Becattini; Amedeo Bongarzoni; Francesca Bux; Franco Casazza; Nicoletta Corrieri; Michele D'Alto; Nicola D'Amato; Andrea Maria D'Armini; Maria Grazia De Natale; Giovanni Di Minno; Giuseppe Favretto; Lucia Filippi; Valentina Grazioli; Gualtiero Palareti; Raffaele Pesavento; Loris Roncon; Laura Scelsi; Antonella Tufano
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

4.  Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study).

Authors:  Jayne Tullett; Ellen Murray; Linda Nichols; Roger Holder; Will Lester; Peter Rose; F D Richard Hobbs; David Fitzmaurice
Journal:  BMC Cardiovasc Disord       Date:  2013-03-09       Impact factor: 2.298

5.  Prevention and treatment of the post-thrombotic syndrome.

Authors:  Arina J Ten Cate-Hoek
Journal:  Res Pract Thromb Haemost       Date:  2018-03-10

6.  Increased inflammation and endothelial markers in patients with late severe post-thrombotic syndrome.

Authors:  Luis Fernando Bittar; Letícia Queiroz da Silva; Fernanda Loureiro de Andrade Orsi; Kiara Cristina Senger Zapponi; Bruna de Moraes Mazetto; Erich Vinícius de Paula; Silmara Aparecida de Lima Montalvão; Joyce Maria Annichino-Bizzacchi
Journal:  PLoS One       Date:  2020-01-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.